Biology Reference
In-Depth Information
Barker E, Bossart KN, Fujimura SH, Levy JA. 1997. CD28 costimulation increases CD8
cell
suppression of HIV replication. J Immunol 159: 5123±5131.
Barker E, Bossart KN, Levy JA. 1998. Primary CD8
cells from HIV-infected individuals can
suppress productive infection of macrophages independent of beta-chemokines. Proc Natl Acad
Sci USA 95: 1725±1729.
Baumler CB, Bohler T, Herr I, et al. 1996. Activation in the CD95 (APO-1/Fas) system in T cells
from human immunode®ciency virus type-1-infected children. Blood 88: 1741±1746.
Benito JM, Zabay JM, Gil J, et al. 1997. Quantitative alterations of the functional distinct subsets
of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of
CD45RO, CD45RA, CD11b, CD38, HLA-DR, CD25 antigens. J AIDS 14: 128±135.
Berger EA, Murphy PM, Farber JM. 1999. Chemokine receptors as HIV-1 coreceptors: roles in
viral entry, tropism, and disease. Annu Rev Immunol 17: 657±700.
Blackbourn DJ, Mackewicz CE, Barker E, et al. 1996. Suppression of HIV replication by lymphoid
tissue CD8
cells correlates with the clinical state of HIV-infected individuals. Proc Natl Acad
Sci USA 93: 13125±13130.
Bo®ll M, Mocroft A, Lipman M, et al. 1996. Increased number of primed activated
CD8
CD38
CD45RO
T cells predict the decline of CD4
T cells in HIV-1-infected patients.
AIDS 10: 827±834.
Bohler T, Baumler C, Herr I, et al. 1997a. Activation of the CD95 system increases with disease
progression in HIV1-infected children and adolescents. Pediatr Infect Dis J 16: 754±759.
Bohler T, Nedel S, Debatin KM. 1997b. CD95-induced apoptosis contributes to loss of primed/
memory but not resting/naive T cells in HIV-1 infected children. Pediatr Res 41: 878±885.
Bohler T, Herr I, Geiss M, et al. 1997c. Downregulation of increased CD95 (APO1/Fas) ligand
expression in T cells following antiretroviral therapy in HIV-1 infected children. Blood 90: 1542±
1599.
Borrow P, Lewicki H, Hahn B, et al. 1994. Virus attractive speci®c CD8
T lymphocytes activity
associated with control of viremia in primary HIV type-1 infection. J Virol 68: 6103±6110.
Borvak J, Chou CS, Bell K, et al. 1995. Expression of CD25 de®nes peripheral blood mononuclear
cells with productive versus latent HIV infection. J Immunol 155: 3196±3204.
Boudet F, Lecoeur H, Gougeon ML. 1997. Apoptosis associated with ex vivo down-regulation of
bcl-2 and up-regulation of Fas in potential cytotoxic CD8
T lymphocytes during HIV infec-
tion. J Immunol 156: 2282±2293.
Burgisser P, Hammann C, Kaufmann D, et al. 1999. Expression of CD28 and CD38 by CD8
T
lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards
normalization under treatment. The Swiss HIV Cohort Study. Clin Exp Immunol 115: 458±463.
Cederbom L, Hall H, Ivars F. 2000. CD4
CD25
regulatory T cells down-regulate co-stimulatory
molecules on antigen-presenting cells. Eur J Immunol 30: 1538±1543.
Cheng J, Zhou T, Liu C, et al. 1994. Protection from Fas-mediated apoptosis by a soluble form of
the Fas molecule. Science 263: 1759±1762.
Choremi-Papadadopoulou H, Viglis V, Gargalianos P, et al. 1994. Down-regulation of CD28 sur-
face antigen on CD4 and CD8 T lymphocytes during HIV-1 infection. J AIDS 7: 245±253.
Clerici M, Shearer GM. 1993. A Th1 ! Th2 switch is a critical step in the etiology of HIV infec-
tion. Immunol Today 14: 107±111.
Clerici M, Shearer GM. 1994. The Th1±Th2 hypothesis of HIV infection: new insights. Immunol
Today 15: 575±581.
Clerici M, Stocks NI, Zajac RC, et al. 1989. Detection of three distinct patterns of T helper cell
dysfunction in asymptomatic human immunode®ciency virus-seropositive patients. Indepen-
dence of CD4
cell numbers and clinical staging. J Clin Invest 84: 1892±1899.
Clerici M, Balotta C, Salvaggio A, et al. 1996a. HIV phenotype and interleukin-2/interleukin-10
ratio are associated markers of protection and progression in HIV infection. Blood 88: 574±579.
